Ebv-Vca An Igg

Lab Reagents

Igg Antibody Laboratories manufactures the ebv-vca an igg reagents distributed by Genprice. The Ebv-Vca An Igg reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igg antibody. Other Ebv-Vca products are available in stock. Specificity: Ebv-Vca Category: An Group: Igg

Igg information

EBV IgG ELISA kit

55R-IB79227 96 wells
EUR 319
Description: ELISA kit for the detection of EBV IgG in the research laboratory

EBV IgG ELISA kit

55R-IB79230 96 wells
EUR 319
Description: ELISA kit for the detection of EBV IgG in the research laboratory

AN-2728

B2220-25
EUR 370

AN-2728

B2220-5
EUR 131

pRI101- AN

PVT11185 2 ug
EUR 370

AN-2690

A3177-10 10 mg
EUR 137
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis.

AN-2690

A3177-100 100 mg
EUR 583
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis.

AN-2690

A3177-5 5 mg
EUR 108
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis.

AN-2690

A3177-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis.

AN-2690

A3177-50 50 mg
EUR 357
Description: Minimum Inhibitory Concentration: 1, 1, 0.5, 0.25, and 0.25 ?g/mL for T.rubrum, T.mentagrophytes, C.albicans, C.neoformans, A.fumigatus, respectivley.AN2690 is a new boron-containing antifungal agent for the potential treatment of onychomycosis.

AN-2728

A3178-10 10 mg
EUR 224
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2].

AN-2728

A3178-5 5 mg
EUR 183
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2].

AN-2728

A3178-5.1 10 mM (in 1mL DMSO)
EUR 195
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2].

AN-2728

A3178-50 50 mg
EUR 572
Description: AN-2728 is an inhibitor of PDE4 with IC50 value of 0.49 ?M [1]. PDE4 is a phosphodiesterase and plays an important role in the chronic inflammation associated with psoriasis and atopic dermatitis [2].

EBV-EA IgG ELISA Kit

DEIA329 96T
EUR 611
Description: The Epstein Barr Virus Early Antigen (EBV-EA) IgG Enzyme-linked Immunosorbent Assay (ELISA), is intended for the detection of IgG antibody to Epstein Barr Virus Nuclear Antigen-1 in human sera and plasma.

Ibrutinib drug-Human IgG Conjugate

IBT17-IgG 100 ug
EUR 529

PAF-AN-1

HY-U00040 5mg
EUR 2198